Factory 99% Montelukast Sodium Powder CAS 151767-02-1 Montelukast Sodium price
TDS 5 Inquiries
151767-02-1
Pharmaceutical Grade
99%
Shanghai
HNB
1kg/bag, 25kg/drum or as request
2026-05-14
Ivermectin,Active pharmaceutical ingredients,Cosmetics material,Chemical intermediate,Nootropic,Food additive
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceWhite or almost white, hygroscopic powder.Montelukast was launched as Singulair in Mexico and Finland for the management of mild to moderate asthma inadequately controlled by inhaled corticosteroids and short-acting beta2-agonists. Montelukast can be obtained by an seven-step synthesis from 3-[2(E)-(7-chloroquinolin-2-yl)vinyl] benzaldehyde. Montelukast is a potent, selective and orally active antagonist of the CysLT1 (formerly called LTD4) Montelukast has been studied extensively in plac
Montelukast sodium is an organic sodium salt. It contains a montelukast(1-).|Montelukast is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma and has been linked to rare cases of clinically apparent liver injury.|Montelukast Sodium is the orally bioavailable monosodium salt of montelukast, a selective cysteinyl leukotriene receptor antagonist with anti-inflammatory and bronchodilating activities. Montelukast selectively and competitively blocks the cysteinyl leukotriene 1 (CysLT1) receptor, preventing binding of the inflammatory mediator leukotriene D4 (LTD4). Inhibition of LTD4 activity results in inhibition of leukotriene-mediated inflammatory events including: migration of eosinophils and neutrophils; adhesion of leukocytes to vascular endothelium, monocyte and neutrophil aggregation; increased airway edema; increased capillary permeability; and bronchoconstriction. The CysLT1 receptor is found in a number of tissues including spleen, lung, placenta, small intestine, and nasal mucosa, and in a variety of cell types including monocyte/macrophages, mast cells, eosinophils, CD34-positive hemopoietic progenitor cells, neutrophils and endothelial cells.CertificatesBasic Info-
Product Name:
Cyclopropaneacetic acid, 1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-, sodium salt (1:1)
Other Name:Cyclopropaneacetic acid,1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-,sodium salt (1:1);Cyclopropaneacetic acid,1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-,monosodium salt,[R-(E)]-;Cyclopropaneacetic acid,1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-,monosodium salt;MK 476;Montelukast sodium;Sodium montelukast;Singulair;Montelukast monosodium salt;2-[1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropyl]acetic acid sodium salt;1-[[[(R)-1-[3-[(E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid sodium salt;Shantroz;Momazol;Sodium 2-[1-[[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)vinyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropyl]acetate;Montair;Montikast;Kokast
CAS No.:151767-02-1
Molecular Formula:C35H36ClNO3S.Na
InChIKeys:InChIKey=ZMFQNQCXWQXCFO-HKHDRNBDSA-N
Molecular Weight:608.17
Exact Mass:607.192383
EC Number:1308068-626-2
UNII:U1O3J18SFL
DSSTox ID:DTXSID8046450
NCI Thesaurus Code:C47625
HScode:2933492250
Categories:
Characteristics-
PSA:
98.6
Appearance:white to tan
Flash Point:407.7ºC
Water Solubility:DMSO: ≥8mg/mL at 60°C
Storage Conditions:-20°C Freezer, Under Inert Atmosphere
Collision Cross Section:227.6 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]|243.2 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Hazard IdentificationClassification of the substance or mixture
Serious eye damage, Category 1
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H318 Causes serious eye damage
Precautionary statement(s) Prevention P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
Response P305+P354+P338 IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P317 Get medical help.
Storage none
Disposal none
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Ivermectin,Active pharmaceutical ingredients,Cosmetics material,Chemical intermediate,Nootropic,Food additive
-
Location:
6 floor Baoyilongji Building B Weiyang Area, Fengcheng 8 Road, Xi'an city, Shaanxi, 710000, China
-
Payment Terms:
L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7 days
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
51-100
-
Year of Establishment:
2017
Company Certificates-
![HNB BiotechISO]( "ISO")
ISO
-
![HNB BiotechISO]( "ISO")
ISO
-
-
Inquiry History5 Inquiries
Country Product Purchase Quantity Date Posted 
Bangladesh
Montelukast Sodium
500 KG Oct 15, 2026 
India
Montillocost Sodium
1000.00 KG Dec 4, 2025 
Pakistan
Montelukast Sodium (Monti)
5.00 KG Oct 9, 2026
Bangladesh
Montelukast sodium
2000.00 KG Dec 11, 2025
India
MONTELUKAST SODIUM
20.00 KG Jun 16, 2025 Post an enquiry for this product
More from this Seller
-
-
![Pharmaceutical grade CAS 616-91-1 N-Acetyl-L-cysteine powder HIGH PURE NAC wholesale price]( "Pharmaceutical grade CAS 616-91-1 N-Acetyl-L-cysteine powder HIGH PURE NAC wholesale price")
-
Pharmaceutical grade CAS 616-91-1 N-Acetyl-L-cysteine powder HIGH PURE NAC wholesale price
Pharmaceutical Grade / 99%
-
-
-
![99% Isavuconazole Isavuconazonium Raw Powder CAS 241479-67-4 Isavuconazole]( "99% Isavuconazole Isavuconazonium Raw Powder CAS 241479-67-4 Isavuconazole")
-
99% Isavuconazole Isavuconazonium Raw Powder CAS 241479-67-4 Isavuconazole
Pharmaceutical Grade / 99%
-
-
-
![Chipco aliette WDG CAS 39148-24-8 Fosetyl aluminum]( "Chipco aliette WDG CAS 39148-24-8 Fosetyl aluminum")
-
Chipco aliette WDG CAS 39148-24-8 Fosetyl aluminum
Pharmaceutical Grade / 99%
-
-
-
![ISO supply High Pure 99% Isoprinosine Raw Powder CAS 36703-88-5 phamaceutical grade]( "ISO supply High Pure 99% Isoprinosine Raw Powder CAS 36703-88-5 phamaceutical grade")
-
ISO supply High Pure 99% Isoprinosine Raw Powder CAS 36703-88-5 phamaceutical grade
Pharmaceutical Grade / 99%
-
